Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07649278 · ClinicalTrials.gov registry record · NA

The ENHANCE Project Toolkit

A NA study, sponsored by University of Wisconsin, Madison.

Not yet
Registry status
NA
Development phase
40
Enrollment target

NCT07649278: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.

NCT07649278 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07649278, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.

NOT YET RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.

Primary Outcome

The Acceptability of Intervention Measure (AIM) measures intervention acceptability with 4 items ranked on a 5-point Likert-type scale. Participants will be asked the 4-item questionnaire for each tool offered in the bundle (3). Scores are averaged across the measure for each tool and subsequently scores for individual tools will be summed to generate a composite acceptability score of the program. Scores can range from 3-15, with higher scores meaning higher acceptability of the intervention

Interventions

  • DEVICE Connections mHealth Application

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-06
Est. Completion 2027-06
Phase NA
University of Wisconsin, Madison

1,039 total trials

What is known before NCT07649278 opens enrollment

NCT07649278 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Connections mHealth Application is the first listed.

NCT07649278 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07649278 about?

NCT07649278 is a clinical study titled "The ENHANCE Project Toolkit". This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.

What is the current status of trial NCT07649278?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07649278?

The interventions under investigation include: Connections mHealth Application (DEVICE).

Who is sponsoring clinical trial NCT07649278?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07649278's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07649278, the US trial registry maintained by the National Library of Medicine. NCT07649278 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.